EUVIMEDEUVIMED entdecken
Crossref

Dasatinib-Loaded Human Serum Albumin Nanoparticle-Impregnated Hydrogel for Localised Eradication of Residual Melanoma: Integrated In Silico , 3D Spheroid, and Dermatokinetic Evaluation

Ganesh Vambhurkar, Paras Famta, Saurabh Shah, Rahul Kumar, Anamika Sharma, Abhishek Sharma, Niharika Puri, Gurpreet Singh, Etikala Amulya, Suraj Wagh, Anupama Sikder, Nitin Pal Kalia und 1 weitere

ACS Applied Bio Materials · 17.08.2026 · 9 (16) · 7512-7536

DOI: 10.1021/acsabm.6c00772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 29.07.2026. Verfasst von Ganesh Vambhurkar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Res…. Hauptthemen laut MEDLINE: Melanoma, Nanoparticles, Dasatinib, Antineoplastic Agents. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to investigate active targeting of residual melanoma cells. Melanoma is the most aggressive form of skin cancer for which the conventional therapies often fail to target post-surgical residual cells owing to challenges like chemoresistance, early metastasis, and recurrence. To mitigate the following issues, we repurposed Dasatinib (DAS), an antineoplastic drug approved for chronic myeloid leukaemia, and evaluated its potential in melanoma treatment through a safe, biomacromolecule-based topical delivery system. DAS-loaded human serum albumin nanoparticles (DNPs) were optimised via Box-Behnken design and incorporated into a hydrogel for localised delivery. The DNPs had a particle size of 125.6 ± 1.58 nm with a polydispersity index of 0.242 ± 0.008 and a zeta potential of –14.28 ± 0.22 mV. ATR-FTIR, PXRD, and DSC analyses demonstrated amorphisation of the drug in DNPs devoid of any chemical interactions. The loading and entrapment efficiencies of DAS in DNPs were estimated to be 7.49 ± 0.28 and 89.80 ± 1.52%, respectively. In vitro assays such as the MTT assay, scratch assay, transwell-based invasive assays, cell cycle assay, and 3D tumoroid-based assays demonstrated superior cytotoxic, anti-invasion, and antimigration properties of DNPs. Mechanistic studies demonstrated that DNPs induced apoptosis via caspase-7 upregulation and downregulation of PI3K, p-mTOR, VEGFR, and EGFR. Dermatokinetic analysis of DNPs-entrapped hydrogel confirmed DNPs accumulation in the epidermal and dermal layers near residual melanoma cells, highlighting their therapeutic potential in the management of residual disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNanoparticlesDasatinibAntineoplastic AgentsHydrogelsBiocompatible MaterialsHumansParticle SizeDrug Screening Assays, AntitumorMaterials TestingCell ProliferationApoptosisDrug CarriersAnimalsCell SurvivalCell Line, Tumor

Stichwörter der Autor:innen

DasatinibHSA nanoparticlesdermatokineticsmelanomatopical delivery

Substanzen

DasatinibAntineoplastic AgentsHydrogelsBiocompatible MaterialsDrug Carriers

Autor:innen und Institutionen

  • Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana500037, India.
  • Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana500037, India.

ORCID-Profile: Saurabh Srivastava

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Vambhurkar, G., Famta, P., Shah, S., Kumar, R., Sharma, A., Sharma, A., Puri, N., Singh, G., Amulya, E., Wagh, S., Sikder, A., Kalia, N. P., & Srivastava, S. (2026). Dasatinib-Loaded Human Serum Albumin Nanoparticle-Impregnated Hydrogel for Localised Eradication of Residual Melanoma: Integrated In Silico , 3D Spheroid, and Dermatokinetic Evaluation. ACS Applied Bio Materials, 9(16), 7512-7536. https://doi.org/10.1021/acsabm.6c00772

Vancouver

Vambhurkar G, Famta P, Shah S, Kumar R, Sharma A, Sharma A, et al. Dasatinib-Loaded Human Serum Albumin Nanoparticle-Impregnated Hydrogel for Localised Eradication of Residual Melanoma: Integrated In Silico , 3D Spheroid, and Dermatokinetic Evaluation. ACS Applied Bio Materials. 2026;9(16):7512-7536. doi:10.1021/acsabm.6c00772

BibTeX
@article{Vambhurkar2026,
  author = {Vambhurkar, Ganesh and Famta, Paras and Shah, Saurabh and Kumar, Rahul and Sharma, Anamika and Sharma, Abhishek and Puri, Niharika and Singh, Gurpreet and Amulya, Etikala and Wagh, Suraj and Sikder, Anupama and Kalia, Nitin Pal and Srivastava, Saurabh},
  title = {Dasatinib-Loaded Human Serum Albumin Nanoparticle-Impregnated Hydrogel for Localised Eradication of Residual Melanoma: Integrated In Silico , 3D Spheroid, and Dermatokinetic Evaluation},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {16},
  pages = {7512--7536},
  doi = {10.1021/acsabm.6c00772}
}
Kostenlos starten →